Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Reagent Enhances PCR and RT-PCR Performance for Difficult Samples

By Labmedica staff writers
Posted on 18 Mar 2008
A new reagent enhances polymerase chain reaction (PCR) and reverse transcriptase (RT)-PCR performance 5-fold or more by improving sensitivity and specificity during amplification of genomic DNA or RNA templates.

Dubbed PCRboost, the reagent greatly improves the amplification of difficult samples, enhancing the yield, specificity, and consistency of the final product. More...
There are no changes needed to existing PCR and RT-PCR protocols--scientists simply replace the water in the reaction with PCRboost. Amplification is drastically improved for all samples, including trace samples (less than or equal to 1 ng), degraded samples, low copy transcripts, multiplexing--short tandem repeat (STR) analysis--and samples containing inhibitory factors.

"With PCRboost, I obtained at least a five-fold increase in the amplification of formalin-fixed, paraffin-embedded [FFPE] cervical cancer tissue samples compared to using water in a standard master mix,” said Mina Kalantari, Ph.D., from the University of California, Irvine (USA). "I start out with very small amounts of degraded DNA and then perform bi-sulfite modification for DNA methylation analysis, which leads to further degradation. Using PCRboost, I am now able to see bands that were invisible without it.”

Introduced by Biomatrica (San Diego, CA, USA), PCRboost is currently available in three formats: a trial kit containing 150-µl of PCRboost, a 1-ml tube, and a 10-ml bottle.

Biomatrica is a biostability company that provides innovative technologies for stabilizing, processing, storing, and shipping biologic samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA and RNA with no sample degradation, enabling labs to reduce their reliance on freezers and drastically reduce shipping costs.

The company also offers SampleWare software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology.


Related Links:
University of California, Irvine
Biomatrica

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Whole-genome sequencing enables broader detection of DNA repair defects to guide PARP inhibitor cancer therapy (Photo courtesy of Illumina)

Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment

Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more

Pathology

view channel
Image: AI models combined with DOCI can classify thyroid cancer subtypes (Photo courtesy of T. Vasse et al., doi 10.1117/1.BIOS.3.1.015001)

AI-Powered Label-Free Optical Imaging Accurately Identifies Thyroid Cancer During Surgery

Thyroid cancer is the most common endocrine cancer, and its rising detection rates have increased the number of patients undergoing surgery. During tumor removal, surgeons often face uncertainty in distinguishing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.